Cargando…
Antibody-mediated oral delivery of therapeutic DNA for type 2 diabetes mellitus
BACKGROUND: Diabetes mellitus (DM) is a chronic progressive metabolic disease that involves uncontrolled elevation of blood glucose levels. Among various therapeutic approaches, GLP-1 prevents type 2 diabetes mellitus (T2DM) patients from experiencing hyperglycemic episodes. However, the short half-...
Autores principales: | Cha, Seungbin, Lee, Sun Hwa, Kang, Sung Hun, Hasan, Mohammad Nazmul, Kim, Young Jun, Cho, Sungpil, Lee, Yong-Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062860/ https://www.ncbi.nlm.nih.gov/pubmed/30065848 http://dx.doi.org/10.1186/s40824-018-0129-7 |
Ejemplares similares
-
Oral Vaccine Delivery for Intestinal Immunity—Biological Basis, Barriers, Delivery System, and M Cell Targeting
por: Kang, Sung Hun, et al.
Publicado: (2018) -
Electrospinning Nanofibers for Therapeutics Delivery
por: Shahriar, S. M. Shatil, et al.
Publicado: (2019) -
Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus
por: Yang, Hae Kyung, et al.
Publicado: (2015) -
Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
por: Kang, Seung Hyun, et al.
Publicado: (2021) -
Exosome-based drug delivery systems and their therapeutic applications
por: Lee, Jaewook, et al.
Publicado: (2022)